Debates & Insights
Debates & Insights/ R&D/ Slider in webinars/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand
Customer engagement and pharma’s field force future
louise.bellamy@pharmaphorum.com
Axtria, customer engagement, field force engagement, pharma's field force
0 Comment
Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars On demand
AI, big data and deep real-world evidence – the challenges and opportunities
louise.bellamy@pharmaphorum.com
AI, big data, BREATHE data research hub, clinical trials, Real World Evidence, RWE, Savana
0 Comment
Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand
Virtual trials and the next generation of pharma clinical research
louise.bellamy@pharmaphorum.com
clinical trials, COVID-19, decentralised trials, NIHR, patient access, virtual trials
0 Comment
Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand
Coordinating and delivering research in the pandemic: The UK approach
louise.bellamy@pharmaphorum.com
clinical research, clinical trial regulation, clinical trials, coronavirus, COVID-19, NIHR, trial recruitment
0 Comment
Debates & Insights/ R&D/ Views & Analysis/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand
Increasing patient engagement with UK clinical trials
louise.bellamy@pharmaphorum.com
clinical trials, compliance, NHS, NIHR, patient engagement, Regulatory affairs, regulatory frameworks
0 Comment
Debates & Insights/ R&D/ Views and analysis/ Webinars/ Webinars in home page/ Webinars On demand
Introducing the new NIHR National Patient Recruitment Centres
louise.bellamy@pharmaphorum.com
access to clinical trials, clinical trials, NHS, NIHR, virtual trials
0 Comment
Debates/ Debates & Insights/ R&D/ Webinars/ Webinars On demand
Vaccines trials in the COVID-19 era and tech’s role in speeding studies
Lynette Arnell
clinical trial data, clinical trials, coronavirus, COVID-19, ERT, patient experience, vaccines
0 Comment
Debates/ Debates & Insights/ R&D/ Webinars/ Webinars On demand
The COVID-19 coronavirus and pharma and biotech continuity planning
louise.bellamy@pharmaphorum.com
api, artificial intelligence, coronavirus, COVID-19, generic medicines, global medicines supply chain, remote detailing
0 Comment